Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17021ExperimentalSmall molecule
First-in-class potent and selective inhibitor of the BRD4 signaling pathway.
- Formula / weight
- C23H25ClN4O2S · 456.99 g/mol (avg)
- Also known as
- (s)-(+)-tert-butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-6-yl)acetate · 6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, 1,1-dimethylethyl ester, (6s)- · Tert-butyl 2-((6s)-4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-6-yl)acetate
- Code names
- (+)-JQ1 · (S)-JQ1
Resolves to
Structure
InChIKey
DNVXATUJJDPFDM-KRWDZBQOSA-NSMILESCC1=C(C)C2=C(S1)N1C(C)=NN=C1[C@H](CC(=O)OC(C)(C)C)N=C2C1=CC=C(Cl)C=C1Targets
What you can answer from here — as of March 06, 2025
2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with JQ1, and which of those have an active Phase 3 trial?